HCA
CLBT icon

Harbour Capital Advisors’s Cellebrite CLBT Stock Holding History

Harbour Capital Advisors’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-22,450
Closed -$358K – 297
2026
Q2 		$358K Buy
22,450
+4,600
+26% +$60.8K 0.07% 230
2026
Q1 		$237K Hold
17,850
– – 0.05% 261
2025
Q4 		$318K Buy
+17,850
New +$321K 0.06% 220

Other funds holding CLBT

Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
EWP
Elevation Wealth Partners Santa Rosa, California $356M AUM 17.04% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return
TFA
Toth Financial Advisory Leesburg, Virginia $1B AUM 19.18% 1-Year Est. Return

Harbour Capital Advisors's CLBT Position: Q3 2026 in Review

Harbour Capital Advisors sold out of Cellebrite (CLBT) in Q3 2026, closing a stake of 22,450 shares — an estimated $358K sold.

Harbour Capital Advisors first reported a position in CLBT in Q4 2025 and held it in 3 quarters. The position peaked at $358K in Q2 2026. 5 funds tracked by Wall St. Rank hold CLBT as of Q3 2026.

  • Harbour Capital Advisors reported no remaining Cellebrite position as of Q3 2026 after selling out during the quarter.
  • Harbour Capital Advisors sold 22,450 Cellebrite shares in Q3 2026, an estimated $358K.
  • Harbour Capital Advisors first reported a position in Cellebrite in Q4 2025 and held it in 3 quarters.
  • Harbour Capital Advisors's Cellebrite position peaked at $358K in Q2 2026.
  • 5 funds tracked by Wall St. Rank held Cellebrite as of Q3 2026.

Based on Harbour Capital Advisors's 13F filing for Q3 2026, filed 13 Oct 2026.